V.M. Dilman

1.0k total citations
37 papers, 816 citations indexed

About

V.M. Dilman is a scholar working on Physiology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, V.M. Dilman has authored 37 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 8 papers in Molecular Biology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in V.M. Dilman's work include Adipose Tissue and Metabolism (6 papers), Birth, Development, and Health (5 papers) and Stress Responses and Cortisol (4 papers). V.M. Dilman is often cited by papers focused on Adipose Tissue and Metabolism (6 papers), Birth, Development, and Health (5 papers) and Stress Responses and Cortisol (4 papers). V.M. Dilman collaborates with scholars based in Russia, United States and United Kingdom. V.M. Dilman's co-authors include Vladimir N. Anisimov, John K. Young, Herman T. Blumenthal, A. G. Golubev, Sergei Revskoy, Khavinson VKh, Е. V. Tsyrlina, Ikuko Kato, Jerzy Karkoszka and Paolo Toniolo and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of the New York Academy of Sciences.

In The Last Decade

V.M. Dilman

37 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V.M. Dilman Russia 16 279 272 198 147 82 37 816
L. Piantanelli Italy 19 242 0.9× 245 0.9× 136 0.7× 136 0.9× 69 0.8× 73 880
Roman Kireev Spain 20 371 1.3× 249 0.9× 98 0.5× 335 2.3× 148 1.8× 37 1.0k
Philippe Laroque United States 13 213 0.8× 84 0.3× 73 0.4× 88 0.6× 123 1.5× 20 575
Reyhan Westbrook United States 14 609 2.2× 329 1.2× 221 1.1× 90 0.6× 159 1.9× 24 1.0k
Fang Zou China 14 338 1.2× 196 0.7× 41 0.2× 429 2.9× 191 2.3× 25 1.0k
Matúš Soták Czechia 16 317 1.1× 184 0.7× 70 0.4× 383 2.6× 154 1.9× 28 797
Aleksandra Mladenović Serbia 16 264 0.9× 266 1.0× 69 0.3× 35 0.2× 28 0.3× 39 789
Cristal M. Hill United States 16 551 2.0× 479 1.8× 256 1.3× 155 1.1× 175 2.1× 27 1.1k
Teresa Fernández‐Agulló Spain 18 428 1.5× 213 0.8× 35 0.2× 375 2.6× 118 1.4× 34 877
Sarah S. Geiger United States 10 304 1.1× 226 0.8× 56 0.3× 433 2.9× 28 0.3× 13 823

Countries citing papers authored by V.M. Dilman

Since Specialization
Citations

This map shows the geographic impact of V.M. Dilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.M. Dilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.M. Dilman more than expected).

Fields of papers citing papers by V.M. Dilman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V.M. Dilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.M. Dilman. The network helps show where V.M. Dilman may publish in the future.

Co-authorship network of co-authors of V.M. Dilman

This figure shows the co-authorship network connecting the top 25 collaborators of V.M. Dilman. A scholar is included among the top collaborators of V.M. Dilman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V.M. Dilman. V.M. Dilman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dilman, V.M.. (2000). [Determination of total cholesterol in small samples of blood].. PubMed. 4(1). 65–8. 1 indexed citations
2.
Kato, Ikuko, Joseph H. Vogelman∥, V.M. Dilman, et al.. (1998). Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil. European Journal of Epidemiology. 14(6). 621–626. 43 indexed citations
3.
Dilman, V.M., et al.. (1995). [The relation of a number of hormonal indices to risk factors for IHD and its prevalence based on the data from a large population study].. PubMed. 67(9). 17–21. 1 indexed citations
4.
Dilman, V.M. & John K. Young. (1994). Development, aging, and disease : a new rationale for an intervention strategy. 60 indexed citations
5.
Dilman, V.M.. (1994). Aging, Rate of Aging and Cancer. Annals of the New York Academy of Sciences. 719(1). 454–455. 2 indexed citations
6.
Dilman, V.M.. (1991). Pathogenetic Approaches to Prevention of Age‐Associated Increase of Cancer Incidence. Annals of the New York Academy of Sciences. 621(1). 385–400. 8 indexed citations
7.
Dilman, V.M.. (1988). Four Models of Medicine: Mechanisms of Aging and Conditions Promoting Cancer Development. Annals of the New York Academy of Sciences. 521(1). 226–227. 2 indexed citations
8.
Dilman, V.M., Sergei Revskoy, & A. G. Golubev. (1986). Neuroendocrine-Ontogenetic Mechanism of Aging: Toward An Integrated Theory of Aging. International review of neurobiology. 28. 89–156. 35 indexed citations
9.
Dilman, V.M.. (1986). Ontogenetic model of ageing and disease formation and mechanisms of natural selection. Journal of Theoretical Biology. 118(1). 73–81. 16 indexed citations
10.
Revskoy, Sergei, et al.. (1985). Age-dependent metabolic immunodepression and cancer.. PubMed. 253–9. 1 indexed citations
11.
Dilman, V.M., et al.. (1981). Peculiarities of hyperlipidaemia in tumour patients. British Journal of Cancer. 43(5). 637–643. 24 indexed citations
12.
Dilman, V.M. & Vladimir N. Anisimov. (1980). Effect of Treatment with Phenformin, Diphenylhydantoin or <i>L</i>-Dòpa on Life Span and Tumour Incidence in C3H/Sn Mice. Gerontology. 26(5). 241–246. 112 indexed citations
13.
14.
15.
16.
Dilman, V.M., et al.. (1979). Increase in lifespan of rats following polypeptide pineal extract treatment. Experimentelle Pathologie. 17(9). 539–545. 28 indexed citations
17.
Dilman, V.M.. (1977). METABOLIC IMMUNODEPRESSION WHICH INCREASES THE RISK OF CANCER. The Lancet. 310(8050). 1207–1209. 28 indexed citations
18.
Anisimov, Vladimir N., et al.. (1976). Effect of the enterotropic carcinogen 1,2-dimethylhydrazine on the hypothalamic biogenic amine level in rats. Bulletin of Experimental Biology and Medicine. 82(5). 1700–1702. 1 indexed citations
19.
Dilman, V.M.. (1970). Growth Hormone, Age and the Endometrium. New England Journal of Medicine. 283(7). 375–375. 1 indexed citations
20.
Dilman, V.M., et al.. (1968). Hypothalamopituitary hyperactivity and endometrial carcinoma. American Journal of Obstetrics and Gynecology. 102(6). 880–889. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Piantanelli Breakdown of academic impact, for papers by Roman Kireev Breakdown of academic impact, for papers by Philippe Laroque Breakdown of academic impact, for papers by Reyhan Westbrook Breakdown of academic impact, for papers by Fang Zou Breakdown of academic impact, for papers by Matúš Soták Breakdown of academic impact, for papers by Aleksandra Mladenović Breakdown of academic impact, for papers by Cristal M. Hill Breakdown of academic impact, for papers by Teresa Fernández‐Agulló Breakdown of academic impact, for papers by Sarah S. Geiger
Rankless by CCL
2026